Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

BACKGROUND: Growth impairment remains common in children with chronic kidney disease (CKD). Available literature indicates low level of recombinant human growth hormone (rhGH) utilization in short children with CKD. Despite efforts at consensus guidelines, lack of high-level evidence continues to co...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Nephrol
Hlavní autoři: Akchurin, Oleh M., Kogon, Amy J., Kumar, Juhi, Sethna, Christine B., Hammad, Hoda T., Christos, Paul J., Mahan, John D., Greenbaum, Larry A., Woroniecki, Robert
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450116/
https://ncbi.nlm.nih.gov/pubmed/28558814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0599-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky